Projects per year
Search results
-
Active
Detection of EAAT1 protein in T-ALL patient samples
Hoogenkamp, M. (Principal Investigator)
1/10/24 → 30/09/25
Project: Research
-
eRaDicate - Innovative ligands for nuclear receptors to eradicate cancer relapse
Hoogenkamp, M. (Co-Investigator), Brown, G. (Principal Investigator) & Stanulovic, V. (Co-Investigator)
UKRI Horizon Europe Underwriting – EPSRC
1/01/24 → 31/12/27
Project: Research
-
Finished
Wellcome TDF: Development of a novel, potent, allosteric EAAT1 inhibitor derived from an in-house hit compound for the treatment of T-cell Acute Lymphoblastic Leukaemia
Jones, A. (Principal Investigator), Hoogenkamp, M. (Co-Investigator) & Stanulovic, V. (Co-Investigator)
1/04/23 → 13/04/24
Project: Research
-
MRC CiC: Establishment of Assays for the Assessment of Functional Activity and Selectivity of Novel EAAT1 Inhibitors
Hoogenkamp, M. (Principal Investigator) & Stanulovic, V. (Co-Investigator)
1/09/22 → 31/03/23
Project: Research Councils
-
Wellcome TDF: Development of Surface Plasmon Resonance (SPR) and Saturation Transfer Difference NMR spectroscopy (STD-NMR) to assess EAAT1 target engagement
Hoogenkamp, M. (Principal Investigator)
1/02/22 → 31/08/22
Project: Research
-
In Vivo Validation of Glutamate-Aspartate Antiporter EAAT1 as a Therapeutic Target for T-Cell Acute Lymphoblastic Leukaemia
Hoogenkamp, M. (Principal Investigator)
1/01/20 → 31/12/20
Project: Research
-
CIC6.2 Drug Development Towards Allosteric Inhibition of EEAT1 for the Treatment of T-ALL
Hoogenkamp, M. (Principal Investigator)
1/03/19 → 29/02/20
Project: Research Councils
-
Uncovering the Function of LM02 in Haematopoietic Development and its Role in the Initiation and Maintenance of Leukaemia
Hoogenkamp, M. (Principal Investigator)
1/04/12 → 31/08/17
Project: Research